Turbine and Harmonic Discovery Pair Simulation-Guided Biology and Multi-Target Kinase Inhibition Chemistry Expertise to Develop a Novel Cancer Therapy
— Companies will co-develop inhibitors of a dark kinase target (NEK1) identified for cancer dependency by Turbine’s Simulated Cell™ platform — LONDON & BUDAPEST, Hungary & NEW YORK--(BUSINESS WIRE)--Turbine, a company that is building the world’s first predictive simulation...